Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

45.61 -0.10 (-0.22%)

Delayed Quote Updated: 10:05 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Spruce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market

June 12, 2025

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates

May 06, 2025

From Spruce Biosciences, Inc.

Via Business Wire

Top movers analysis one hour before the close of the markets on 2025-04-28: top gainers and losers in today's session. ↗

April 28, 2025

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

These stocks are moving in today's session ↗

April 28, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 28, 2025

Via Benzinga

Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook ↗

April 28, 2025

Via Benzinga

Which stocks are gapping on Monday? ↗

April 28, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

These stocks are moving in today's pre-market session ↗

April 28, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings ↗

April 28, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 28, 2025

Via Benzinga

Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

April 28, 2025

Via Benzinga

Which stocks have an unusual volume on Monday? ↗

April 21, 2025

In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.

Via Chartmill

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

April 17, 2025

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

Via Chartmill

These stocks have an unusual volume in today's session ↗

April 16, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Top stock movements in today's session. ↗

April 15, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Tuesday's session: top gainers and losers ↗

April 15, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 15, 2025

Via Benzinga

The market is filled with gapping stocks in Tuesday's session. ↗

April 15, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Via Chartmill

Crude Oil Moves Lower; Citigroup Posts Upbeat Results ↗

April 15, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

April 15, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Nasdaq Surges 100 Points; Bank of America Earnings Top Views ↗

April 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 15, 2025

Via Benzinga

Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

April 15, 2025

From Spruce Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 31, 2025

Via Benzinga

Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder ↗

December 11, 2024

Spruce Biosciences discontinues tildacerfont trials for CAH as CAHmelia-204 misses primary endpoint and CAHptain-205 shows dose-dependent trends.

Via Benzinga

Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH

December 10, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

November 11, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference

October 28, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

September 03, 2024

From Spruce Biosciences, Inc.

Via Business Wire

SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024 ↗

August 12, 2024

SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.